A 44-year-old woman, who was diagnosed with systemic lupus erythematosus (SLE) based on the presence of malar rash, arthritis, anti-nuclear and anti-DNA antibodies, and leukocytopenia, remained in a stable condition while receiving 10 mg prednisolone (PSL). She developed a fever, complex partial seizure, and disturbance in consciousness. Anti-DNA antibody titers and serum complement levels were within the normal limits. Mild leukocytopenia (3,200/μL) was observed. A cerebrospinal fluid (CSF) analysis revealed mononuclear pleocytosis (28 cells/mm^3^), elevated protein levels (62 mg/dL), and normal glucose levels. T2-weighted, fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI) indicated bilateral signal hyperintensity in the hippocampus and amygdala ([Picture A](#g001){ref-type="fig"}, arrows). Whole-body computed tomography excluded malignancy. Acyclovir was given under the presumptive diagnosis of human herpes virus (HHV) encephalitis, but neither HHV-6 virus DNA or anti-N-methyl-D-aspartate receptor antibody was detected in the CSF. Limbic encephalitis with SLE was suspected. High-dose steroid therapy improved her clinical symptoms immediately. FLAIR MRI demonstrated an improvement in the limbic encephalitis ([Picture B](#g001){ref-type="fig"}) and hippocampus atrophy ([Picture C](#g001){ref-type="fig"}, arrows) at one and four months after therapy initiation, respectively. Limbic encephalitis in association with SLE has rarely been reported ([@B1],[@B2]).
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